EVOGENE LTD. Research and Development Expense
EVOGENE LTD. (EVGN) reported Research and Development Expense of $7.99 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-26
| Period end | Research And Development Expense 6 month | Research And Development Expense 6 month as first filed | Research And Development Expense 12 month | Research And Development Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $7.99M 20-F · filed 2026-03-26 | |||
| 2025-06-30 | $4.79M 6-K · filed 2025-09-30 | |||
| 2024-12-31 | $12.51M 20-F · filed 2026-03-26 | $16.65M 20-F · filed 2025-03-27 | ||
| 2024-06-30 | $6.50M 6-K · filed 2025-09-30 | $8.82M 6-K · filed 2024-09-16 | ||
| 2023-12-31 | $16.20M 20-F · filed 2026-03-26 | $20.78M 20-F · filed 2024-03-28 | ||
| 2023-06-30 | $10.17M 6-K · filed 2024-09-16 | |||
| 2022-12-31 | $20.79M 20-F · filed 2025-03-27 | |||
| 2022-06-30 | $11.04M 6-K · filed 2023-09-13 | |||
| 2021-12-31 | $21.13M 20-F · filed 2024-03-28 | |||
| 2021-06-30 | $9.28M 6-K · filed 2022-09-07 | |||
| 2020-12-31 | $17.29M 20-F · filed 2023-03-30 | |||
| 2020-06-30 | $8.48M 6-K · filed 2021-08-31 | |||
| 2019-12-31 | $15.79M 20-F · filed 2022-03-31 | |||
| 2019-06-30 | $7.02M 6-K · filed 2020-09-15 | |||
| 2018-12-31 | $14.69M 20-F · filed 2021-04-02 | |||
| 2017-12-31 | $16.99M 20-F · filed 2020-04-27 | |||
| 2016-12-31 | $16.41M 20-F · filed 2019-04-29 | |||
| 2015-12-31 | $14.45M 20-F · filed 2018-03-30 |